Screener Summaries Updates Institutions Sign In More Updates › Earnings › ODTX Earnings · Jun 17, 2026
Odyssey Therapeutics, Inc. announced its financial results for the quarter ended March 31, 2026, on June 17, 2026 ODTX Odyssey Therapeutics, Inc.
Odyssey Therapeutics, Inc. announced its financial results for the quarter ended March 31, 2026, on June 17, 2026. The company is a biotechnology company focused on developing therapeutic solutions for inflammatory and inflammatory-driven diseases.
More from Odyssey Therapeutics, Inc. Reports Q3 net loss of $53.1M and appoints new chief medical officer Nov 4, 2026 Odyssey Therapeutics reports Phase 2a induction results for ulcerative colitis drug OD-001 Oct 20, 2026 Odyssey Therapeutics, Inc. filed a Form 8-K on September 8, 2026, to furnish Exhibit 99.1, a corporate presentation… Sep 8, 2026 Odyssey Therapeutics reported financial results for the second quarter ended June 30, 2026, reporting a net loss of… Aug 4, 2026 Odyssey Therapeutics, Inc. posted a corporate presentation on its website on June 23, 2026 Jun 23, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
